Company Filing History:
Years Active: 2021
Title: Felix Ellett: Innovator in Microfluidic Technology
Introduction
Felix Ellett is a notable inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of microfluidics, particularly in the development of devices that aid in disease detection. His innovative work focuses on enhancing the understanding of neutrophil behavior, which is crucial for diagnosing various medical conditions.
Latest Patents
Felix Ellett holds a patent for "Microfluidic neutrophil assays and systems for disease detection." This patent relates to microfluidic devices and methods designed to monitor the directionality, velocity, and migration persistence of neutrophils or other cells without the influence of chemical gradients. The technology allows for the detection and quantification of abnormal neutrophil motility phenotypes using low sample volumes and minimal activation of the neutrophils. These devices and methods are particularly useful for diagnosing sepsis in patients suspected of having the condition or at risk of developing it. Additionally, they can be employed to monitor patient responses to sepsis therapies.
Career Highlights
Felix Ellett is associated with The General Hospital Corporation, where he applies his expertise in microfluidic technology. His work has the potential to revolutionize how medical professionals diagnose and treat sepsis, ultimately improving patient outcomes.
Collaborations
Felix collaborates with esteemed colleagues, including Daniel Irimia and Julianne Jorgensen. Their combined efforts contribute to advancing research in the field of microfluidics and disease detection.
Conclusion
Felix Ellett's innovative contributions to microfluidic technology exemplify the impact of inventors in the medical field. His work not only enhances diagnostic capabilities but also paves the way for improved patient care.